Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1998-11-17
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1078-0467
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
285-312
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading | |
| pubmed:year |
1998
|
| pubmed:articleTitle |
Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylate.
|
| pubmed:affiliation |
Discovery Chemistry, Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49001-0199, USA.
|
| pubmed:publicationType |
Journal Article,
Review
|